Despite Medicare coverage, drug may remain out of reach for many patients, policy experts say
You are here: Home / Top Stories / : FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage
Market News and Views
Despite Medicare coverage, drug may remain out of reach for many patients, policy experts say